STING expression and response to treatment with STING ligands in premalignant and malignant disease

Stimulating Innate Immunity to Enhance Radiation Therapy–Induced Tumor Control

(2017) Jason R. Baird et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Established T Cell-Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade

(2016) E. Moore et al.   Cancer Immunology Research

Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors

(2015) J. R. Baird et al.   CANCER RESEARCH

Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma

(2015) Dany Nassar et al.   NATURE MEDICINE

Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity

(2015) Leticia Corrales et al.   Cell Reports

The Peripheral Myeloid Expansion Driven by Murine Cancer Progression Is Reversed by Radiation Therapy of the Tumor

(2013) Marka R. Crittenden et al.   PLoS One

Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia

(2011) Deirdre R. Pachman et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Identifying the cellular origin of squamous skin tumors

(2011) G. Lapouge et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Clinician's guide to human papillomavirus immunology: knowns and unknowns

(2009) Mark H Einstein et al.   LANCET INFECTIOUS DISEASES